Anti-YIPF2 monoclonal antibody

Pre-made anti-YIPF2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to YIPF2/YIPF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2288-Ab-1/ GM-Tg-hg-IP2288-Ab-2Anti-Human YIPF2 monoclonal antibodyHuman
GM-Tg-rg-IP2288-Ab-1/ GM-Tg-rg-IP2288-Ab-2Anti-Rat YIPF2 monoclonal antibodyRat
GM-Tg-mg-IP2288-Ab-1/ GM-Tg-mg-IP2288-Ab-2Anti-Mouse YIPF2 monoclonal antibodyMouse
GM-Tg-cynog-IP2288-Ab-1/ GM-Tg-cynog-IP2288-Ab-2Anti-Cynomolgus/ Rhesus macaque YIPF2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2288-Ab-1/ GM-Tg-felg-IP2288-Ab-2Anti-Feline YIPF2 monoclonal antibodyFeline
GM-Tg-cang-IP2288-Ab-1/ GM-Tg-cang-IP2288-Ab-2Anti-Canine YIPF2 monoclonal antibodyCanine
GM-Tg-bovg-IP2288-Ab-1/ GM-Tg-bovg-IP2288-Ab-2Anti-Bovine YIPF2 monoclonal antibodyBovine
GM-Tg-equg-IP2288-Ab-1/ GM-Tg-equg-IP2288-Ab-2Anti-Equine YIPF2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2288-Ab-1/ GM-Tg-hg-IP2288-Ab-2; GM-Tg-rg-IP2288-Ab-1/ GM-Tg-rg-IP2288-Ab-2;
GM-Tg-mg-IP2288-Ab-1/ GM-Tg-mg-IP2288-Ab-2; GM-Tg-cynog-IP2288-Ab-1/ GM-Tg-cynog-IP2288-Ab-2;
GM-Tg-felg-IP2288-Ab-1/ GM-Tg-felg-IP2288-Ab-2; GM-Tg-cang-IP2288-Ab-1/ GM-Tg-cang-IP2288-Ab-2;
GM-Tg-bovg-IP2288-Ab-1/ GM-Tg-bovg-IP2288-Ab-2; GM-Tg-equg-IP2288-Ab-1/ GM-Tg-equg-IP2288-Ab-2
Products NameAnti-YIPF2 monoclonal antibody
Formatmab
Target NameYIPF2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-YIPF2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2288-Ag-1Recombinant multi-species YIPF2/ FinGER2 protein
    ORF Viral VectorpGMLP000445human YIPF2 Lentivirus plasmid
    ORF Viral VectorvGMLP000445human YIPF2 Lentivirus particle
    ORF Viral VectorpGMLPm000470mouse Yipf2 Lentivirus plasmid
    ORF Viral VectorpGMLPm005400mouse Yipf2 Lentivirus plasmid
    ORF Viral VectorvGMLPm000470mouse Yipf2 Lentivirus particle
    ORF Viral VectorvGMLPm005400mouse Yipf2 Lentivirus particle


    Target information

    Target IDGM-IP2288
    Target NameYIPF2
    Gene ID78992,74766,363027,713753,484946,101101290,515893,100146288
    Gene Symbol and Synonyms1300010K09Rik,FinGER2,RGD1307512,YIPF2
    Uniprot AccessionQ9BWQ6,Q5XIT3
    Uniprot Entry NameYIPF2_HUMAN,YIPF2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130733
    Target ClassificationN/A

    The target: YIPF2, gene name: YIPF2, also named as FinGER2. Predicted to enable small GTPase binding activity. Predicted to be involved in vesicle-mediated transport. Located in Golgi apparatus subcompartment and transport vesicle. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.